We are live on ! Find out more
OSIR

Osiris Therapeutics, Inc. Common Stock
OSIR

Delisted

OSIR was delisted on the 16th of April, 2019.

Back to rankings

56 hedge funds and large institutions have $47.4M invested in Osiris Therapeutics, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 56 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more call options, than puts

Call options by funds: $1.26M | Put options by funds: $887K

Holders
56
Holders Change
+56
Holders Change %
–
% of All Funds
1.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
56
Increased
–
Reduced
–
Closed
–
Calls
$1.26M
Puts
$887K
Net Calls
+$373K
Net Calls Change
+$373K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$209K +$220K +20,904 New
TA
27
Teachers Advisors
New York
$207K +$216K +20,600 New
Swiss National Bank
28
Swiss National Bank
Switzerland
$204K +$213K +20,300 New
KG
29
Killen Group
Pennsylvania
$201K +$210K +20,000 New
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$199K +$208K +19,790 New
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$193K +$202K +19,209 New
WC
32
Woodstock Corp
Massachusetts
$189K +$197K +18,780 New
SB
33
Suntrust Banks
Georgia
$189K +$198K +18,887 New
Renaissance Technologies
34
Renaissance Technologies
New York
$182K +$190K +18,107 New
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$172K +$179K +17,040 New
Jane Street
36
Jane Street
New York
$172K +$180K +17,128 New
ProShare Advisors
37
ProShare Advisors
Maryland
$171K +$179K +16,991 New
HK
38
Horizon Kinetics
New York
$161K +$168K +16,000 New
Bank of America
39
Bank of America
North Carolina
$158K +$165K +15,699 New
MLICM
40
Metropolitan Life Insurance Company (MetLife)
New York
$155K +$162K +15,436 New
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$146K +$152K +14,468 New
NFA
42
Nationwide Fund Advisors
Ohio
$127K +$132K +12,603 New
Group One Trading
43
Group One Trading
Illinois
$126K +$131K +12,484 New
Public Employees Retirement Association of Colorado
44
Public Employees Retirement Association of Colorado
Colorado
$121K +$126K +11,982 New
AIG
45
American International Group
New York
$114K +$119K +11,336 New
BA
46
BlackRock Advisors
Delaware
$104K +$109K +10,373 New
Morgan Stanley
47
Morgan Stanley
New York
$103K +$107K +10,225 New
RFC
48
Russell Frank Company
Washington
$95K +$99K +9,419 New
U
49
UBS
Switzerland
$60K +$62.4K +5,936 New
GT
50
Glenmede Trust
Pennsylvania
$54K +$56.7K +5,400 New
1
2
3

OSIR Hedge Fund Activity: Q2 2013 in Review

56 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q2 2013, worth a combined $47.4M.

Buyers outnumbered sellers: 56 funds opened new OSIR positions and 0 closed out — a net gain of 56 holders — while 0 added to existing stakes and 0 trimmed.

  • 56 institutional investors held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $47.4M of Osiris Therapeutics, Inc. Common Stock stock for Q2 2013.
  • 56 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q2 2013 and 0 closed out, a net change of +56 holders.

Based on aggregated 13F filings for Q2 2013.